Levosimendan In Ambulatory Heart Failure Patients (LEIA-HF)

NCT04705337 PHASE4 TERMINATED

The objective of the study is to determine the efficacy of repeated infusions of levosimendan in the group of outpatients with advanced systolic heart failure (HF).

Details

Lead sponsor	Medical University of Bialystok
Phase	PHASE4
Status	TERMINATED
Enrolment	70
Start date	Wed Dec 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Aug 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Heart Failure New York Heart Association Class III
• Heart Failure New York Heart Association Class IV
• Heart Failure, Systolic
• Heart Failure With Reduced Ejection Fraction

Interventions

• Levosimendan
• Placebo

Countries

Poland